Drug-drug interactions in atrial fibrillation patients receiving direct oral anticoagulants

Polypharmacy is common in patients with atrial fibrillation (AF), making these patients vulnerable to the occurrence of potential drug-drug interactions (DDIs). We assessed the risk of ischemic stroke and major bleeding in the context of concomitant treatment with potential DDIs in patients with AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Yun, Oh, Il-Young, Lee, Ju-Hyeon, Kim, Seok, Cho, Jihoon, Park, Charg Hyun, Yoo, Sooyoung, Bang, Soo-Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599657/
https://www.ncbi.nlm.nih.gov/pubmed/34789799
http://dx.doi.org/10.1038/s41598-021-01786-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599657/
https://www.ncbi.nlm.nih.gov/pubmed/34789799
http://dx.doi.org/10.1038/s41598-021-01786-2

Ejemplares similares